Table 2 Tabulation of results of Aptima and the TaqPath on diluted clinical samples
Control dilution | TaqPath N-gene (Cq value) | Aptima results | Alinity m (CN value) |
|---|---|---|---|
Undiluted (1) | |||
1:2 | 25.59 | Positive | |
1:10 | 28.70 | Positive | |
1:20 | 29.93 | Positive | |
1:50 | 29.26 | Positive | |
Undiluted (2) | |||
1:2 | 25.64 | Positive | |
1:10 | 28.93 | Positive | |
1:20 | 30.44 | Positive | |
1:50 | 31.08 | Positive | |
Undiluted (3) | |||
1:2 | 25.52 | Positive | |
1:10 | 28.82 | Positive | |
1:20 | 29.11 | Positive | |
1:50 | 30.66 | Positive | |
Undiluted (4) | |||
1:2 | 23.33 | Positive | |
1:10 | 26.53 | Positive | |
1:20 | 27.66 | Positive | |
1:50 | 28.89 | Positive | |
Undiluted (5) | |||
1:2 | 28.20 | Positive | |
1:10 | 31.41 | Positive | |
1:20 | ND* | Positive | 32.81 |
1:50 | ND* | Positive | 34.07 |
Undiluted (6) | |||
1:2 | 24.36 | Positive | |
1:10 | 27.41 | Positive | |
1:20 | 27.57 | Positive | |
1:50 | 28.67 | Positive | |
Undiluted (7) | |||
1:2 | 28.32 | Positive | |
1:10 | 32.00 | Positive | |
1:20 | ND* | Positive | 32.59 |
1:50 | ND* | Positive | 34.41 |
Undiluted (8) | |||
1:2 | 24.20 | Positive | |
1:10 | 26.91 | Positive | |
1:20 | 28.27 | Positive | |
1:50 | 29.47 | Positive | |
Undiluted (9) | |||
1:2 | 26.04 | Positive | |
1:10 | 29.13 | Positive | |
1:20 | 29.43 | Positive | |
1:50 | 30.27 | Positive | |
Undiluted (10) | |||
1:2 | 25.25 | Positive | |
1:10 | 28.06 | Positive | |
1:20 | 29.09 | Positive | |
1:50 | 30.11 | Positive | |